These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The potential of molecular screening. Ahrendt SA; Sidransky D Surg Oncol Clin N Am; 1999 Oct; 8(4):641-56, vi. PubMed ID: 10452932 [TBL] [Abstract][Full Text] [Related]
8. [What can we expect from identification of mutations of the phenylalanine hydroxylase gene?]. Rey J; Rey F Arch Fr Pediatr; 1992 Jan; 49(1):1-3. PubMed ID: 1550444 [No Abstract] [Full Text] [Related]
9. Microsatellite instability: marker of a mutator phenotype in cancer. Loeb LA Cancer Res; 1994 Oct; 54(19):5059-63. PubMed ID: 7923117 [No Abstract] [Full Text] [Related]
10. Individualized cancer therapy: molecular approaches to the prediction of tumor response. McLeod HL Expert Rev Anticancer Ther; 2002 Feb; 2(1):113-9. PubMed ID: 12113060 [TBL] [Abstract][Full Text] [Related]
14. Tumour markers - new aspects of an old discussion? Fleischhacker M; Beinert T Eur J Med Res; 1999 Apr; 4(4):144-8. PubMed ID: 10205289 [TBL] [Abstract][Full Text] [Related]
15. [The mouse embryogenesis of jumonji mutant obtained by gene-trap method]. Motoyama J; Takeuchi T Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2152-61. PubMed ID: 8532871 [No Abstract] [Full Text] [Related]
16. Genes and chromosomes. Part 3--Genes, proteins and mutations. Bexfield A; Nigam Y Nurs Times; 2008 Jun 24-30; 104(25):26-7. PubMed ID: 18672839 [No Abstract] [Full Text] [Related]
17. Human Gene Mutation Database (HGMD): 2003 update. Stenson PD; Ball EV; Mort M; Phillips AD; Shiel JA; Thomas NS; Abeysinghe S; Krawczak M; Cooper DN Hum Mutat; 2003 Jun; 21(6):577-81. PubMed ID: 12754702 [TBL] [Abstract][Full Text] [Related]